Smallpox drugmakers jump as WHO calls for increased Monkeypox surveillance

Chimerix

26/05/2022 19:39

** Shares of some U.S. smallpox vaccine and drugmakers jump
between 4% and 24%
    ** About 200 confirmed and more than 100 suspected cases of
Monkeypox have been detected so far outside of the countries
where it usually spreads, a World Health Organization official
says, urging countries to increase surveillance  urn:newsml:reuters.com:*:nL3N2XI361
    ** GeoVax Labs  GOVX.O  jumps surges 24%; Tonix
Pharmaceuticals  TNXP.O  and SIGA Technologies  SIGA.O  are up
4.5% and 11.5%, respectively, both on course to snap a three-day
losing streak
    ** The United States confirms nine Monkeypox cases in seven
states as of Wednesday
    ** Cases were confirmed in Massachusetts, Florida, Utah,
Washington, California, Virginia and New York, according to the
U.S. Centers for Disease Control and Prevention (CDC)
 urn:newsml:reuters.com:*:nL2N2XI1TO
    ** SIGA shares logged their biggest weekly gain since
October 2006 last week, when the first Monkeypox case in the
United States was reported in Massachusetts
    ** Shares of Emergent BioSolutions  EBS.N , which is buying
FDA-approved smallpox drug Tembexa from drugmaker Chimerix
 CMRX.O , is down nearly 4%; CMRX is marginally up

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))